Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.

Barboza, Nora M

Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab. [electronic resource] - Cancer biology & therapy Jan 2012 - 114-22 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1555-8576

10.4161/cbt.13.2.18876 doi


Animals
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antigens, CD20--genetics
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
Burkitt Lymphoma--drug therapy
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Depsipeptides--administration & dosage
Female
Humans
Immunophenotyping
Lymphoma, Large B-Cell, Diffuse--drug therapy
Mice
Mice, Nude
Peptides, Cyclic
Rituximab
Xenograft Model Antitumor Assays